Devyser is specialised in the development, manufacturing and sales of in-vitro diagnostics products for genetic testing. The company was founded in Stockholm in 2005 and has introduced more than 20 products to genetic laboratories worldwide. The products are used to guide targeted cancer therapies, for rapid prenatal diagnostics, genetic testing and reproductive health. Devysers’ products enable higher speed, accuracy and cost-effectiveness in diagnostic services. www.devyser.com.